Atrás
Precio Inhibikase Therapeutics Inc (IKT)
Gráfico del Precio de Acciones IKT
IKT Dividendos
Inhibikase Therapeutics Inc
$1.67
1.82%
$0.03
Al cierre: Feb 13, 16:00:00 GMT-5
$1.65
-1.19%
$-0.02
Mercado Posterior: Feb 13, 20:00:00 GMT-5
Estadísticas clave
Cierre Anterior
$1.64
Precio de apertura
$1.64
Rango del día
$1.64 - $1.73
Rango de 52 semanas
$1.33 - $3.32
Volumen
218.2K
Volumen promedio
449.4K
EPS (TTM)
-1.15
Rendimiento de dividendos
--
Cap. de mercado
$199.4M
¿Qué es IKT?
Inhibikase Therapeutics, Inc. is a clinical-stage pharmaceutical company, which engages in development of protein kinase inhibitor therapeutics to modify the course of Parkinson's-related disorders and other diseases of the Abelson Tyrosine Kinases. The company is headquartered in Wilmington, Delaware and currently employs 15 full-time employees. The company went IPO on 2020-12-23. The firm is focused on developing Abelson Tyrosine Kinase inhibitor therapeutics for cardiopulmonary disease. The Company’s multi-therapeutic pipeline includes IKT-001, a prodrug of imatinib mesylate, for pulmonary arterial hypertension (PAH).
Características
© 2026 Finture Development Limited. Todos los derechos reservados.
